Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-096942
Filing Date
2025-07-18
Accepted
2025-07-18 16:27:42
Documents
1
Period of Report
2025-07-18

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3579
  Complete submission text file 0000950170-25-096942.txt   5197
Mailing Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036 2129978500
HESS CORP (Issuer) CIK: 0000004447 (see all company filings)

EIN.: 134921002 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2911 Petroleum Refining
(CF Office: 01 Energy & Transportation)

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Quigley James H. (Reporting) CIK: 0001554331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-01204 | Film No.: 251134804